SCHEMBL8728241

SCHEMBL8728241

CC(C)C(=O)Oc1cc(-c2cn3c(n2)sc2ccccc23)cc([N+](=O)[O-])c1OC(=O)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
FLT3 P36888 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RPS6KA3 P51812 2/20 0.37
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367277 0.78 MET (0.40) POLBRAB9ASMN1; SMN2LMNATP53
SCHEMBL7365147 0.77 FLT3 (0.42) POLBRAB9ASMN1; SMN2LMNATP53
SCHEMBL8733137 0.77 MAPT (0.40) RAB9ASMN1; SMN2TP53MAPTNPC1
SCHEMBL11012268 0.77 MAPT (0.46) POLBRAB9ASMN1; SMN2LMNATP53
SCHEMBL7369595 0.75 HPGD (0.46) RAB9ATP53MAPTALDH1A1
SCHEMBL7367777 0.74 MAPT (0.54) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL11004327 0.71 CASP3 (0.53) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL73916 0.71 MBD2 (0.58) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL8726194 0.70 PIK3CA (0.43) RAB9ASMN1; SMN2LMNAMAPTTSHR
SCHEMBL11005976 0.69 TP53 (0.55) POLBRAB9ASMN1; SMN2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed